Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 1.91 Delayed Data As of May 23 |  +0.04 / +2.13%Today’s Change | 1.60 Today|||52-Week Range 10.33 | -61.72% Year-to-Date |
Latest INO News | Press Releases
| Is This Vaccine Stock in Trouble -- or Ready for a Rebound? May 13 / MotleyFool.com - Paid Partner Content | Inovio Pharmaceuticals (INO) Reports Q1 Loss, Lags Revenue Estimates May 10 / Zacks.com - Paid Partner Content |
| Inovio Pharmaceuticals (INO) Q1 2022 Earnings Call Transcript May 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.88 |
| Today’s open | 2.16 |
| Day’s range | 1.89 - 2.16 |
| Volume | 11,908,841 |
| Average volume (3 months) | 5,294,357 |
| Market cap | $427.2M |
Data as of 4:00pm ET, 05/23/2022
Growth & Valuation
| Earnings growth (last year) | -35.56% |
| Earnings growth (this year) | +19.66% |
| Earnings growth (next 5 years) | +22.71% |
| Revenue growth (last year) | -76.05% |
| P/E ratio | NM |
| Price/Sales | 587.16 |
| Price/Book | 1.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IDYAIDEAYA Biosciences I... | -0.26 | -2.36% |
| ---- | ||
| ALBOAlbireo Pharma Inc | -0.76 | -3.41% |
| YMABY-mAbs Therapeutics ... | +0.59 | +5.89% |
Data as of 4:00pm ET, 05/23/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $1.8M |
| Annual profit (last year) | -$303.7M |
| Net profit margin | -17,109.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
